Method and system for treatment planning
By adjusting the defined dose value of the surrounding area in the radiotherapy plan and optimizing the radiotherapy plan, the problems of time-consuming and heavy calculation burden in the existing technology are solved, and the accuracy and efficiency of the treatment plan are improved.
Patent Information
- Application Number
- CN202410579760.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-11
- Filing Date
- 2024-05-11
- Publication Date
- 2024-11-12
AI Technical Summary
The generation process of existing radiation therapy plans is time-consuming and computationally burdensome, especially due to the inefficiency of the optimization process due to unrealistic defined dose values, resulting in inaccurate and suboptimal treatment plans generated.
By receiving treatment plan parameters, including the reference dose value of the targeted area and the defined dose value of the surrounding area, determine whether the defined dose value exceeds the threshold, if not exceeded, modify the defined dose value, and use the modified dose value to optimize the radiation therapy plan, automatically Adjust dose distribution to improve the accuracy and efficiency of the optimization process.
Improve the generation speed and accuracy of radiation therapy plans, automate the generation process of treatment plans, ensure that the optimization process is carried out in a feasible computing space, and avoid inefficiency and suboptimal planning caused by unrealistic low dose values.
Smart Images

Figure CN118942630A_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to methods and systems for treatment planning. More specifically, the present disclosure relates to a computer-implemented method for radiation therapy planning and a data processing device, a computer program and a non-transitory computer-readable storage medium configured to execute the method for radiation therapy planning. Background Art
[0002] Radiation therapy, or radiotherapy, can be described as the use of ionizing radiation to damage or destroy unhealthy cells in humans and animals. Ionizing radiation can be directed to tumors on the surface of the skin or deep inside the body. Common forms of ionizing radiation include X-rays and charged particles. An example of a radiotherapy technique is a gamma knife that irradiates a patient using multiple lower intensity gamma rays focused at a higher intensity and high precision on a targeted area, such as a tumor. Another example of radiation therapy includes the use of a linear accelerator ("linac"), whereby a targeted area is irradiated with high energy particles (e.g., electrons, high energy photons, etc.). In another example, radiation therapy can be provided using a heavy charged particle accelerator (e.g., protons, carbon ions, etc.).
[0003] The placement and dosage of radiation beams can be precisely controlled to provide a prescribed dose of radiation to a targeted area (e.g., a tumor) and to reduce damage to surrounding healthy tissue (referred to as organs at risk or OARs). One aspect of treatment planning involves determining appropriate characteristics of the radiation to be delivered to produce a safe and effective dose. For example, the characteristics of the radiation relate to the flux pattern or distribution. The flux pattern may depend on the beam arrangement, energy, and field size, which in turn are related to controllable parameters (which are optimizable). By determining appropriate values for these parameters, an appropriate flux pattern may be obtained. The treatment plan may be determined by a treatment planning system.
[0004] An optimization procedure can be used to establish a radiation therapy treatment plan (treatment plan, or simply plan) to determine the optimal parameter values or the set of optimal variable values that are expected to deliver an appropriate dose. The optimization process can be based on clinical and dosimetric goals and constraints. Examples of clinical and dosimetric goals and constraints include maximum, minimum, and mean doses to the targeted area and surrounding areas (such as tumors and critical organs). Clinical and dosimetric goals and constraints can be referred to as treatment plan goals. Optimization is typically performed with respect to one or more treatment plan parameters to shorten beam on time, improve dose uniformity, etc.
[0005] The treatment planning process can include using images (two-dimensional or three-dimensional) of the patient to identify the target area and identify critical organs near the target area. Segmentation can be used to identify the target area (or area to be treated, for example, the Planned Target Volume (PTV) and the surrounding area (or Organ At Risk (OAR)). After segmentation, a dose plan can be created for the patient, which indicates the desired amount of radiation to be received by the target area and / or the surrounding area. The target area can have an irregular volume and can be significantly different in size, shape, and location.
[0006] In a practical example, there may be multiple anatomical structures (targeted areas and / or surrounding areas). For example, in head and neck treatment, there may be more than 20 anatomical structures. For each structure, it may be desirable to comply with various treatment plan goals. In order to arrive at a clinically acceptable plan, these structures and their goals may be assigned different priorities. Determining a treatment plan that meets the various goals is time-consuming and complex.
[0007] The creation of a radiation therapy plan is typically a time-consuming process in which the planner attempts to comply with various treatment goals or constraints, possibly taking into account their own importance, to produce a clinically acceptable radiation therapy plan. Common problems faced when creating radiation therapy plans involving optimization processes include lengthy optimization times and high computational burdens required to achieve safe and satisfactory results. These processes typically involve trial and error on the part of the user (e.g., treatment planner, dosimetrist, clinician, or healthcare worker), which can be time-consuming and further complicated as further goals and constraints are added.
[0008] Therefore, it is desirable to reduce planning time through improved radiotherapy treatment planning workflow. Summary of the invention
[0009] According to one aspect, a computer-implemented method for radiation therapy treatment planning is provided. The method includes receiving treatment plan parameters, the treatment plan parameters including a reference dose value for a target region of a patient and a defined dose value for a surrounding region. The method also includes determining whether the defined dose value for the surrounding region exceeds a threshold. The method also includes modifying the defined dose value for the surrounding region in response to determining that the defined dose value for the surrounding region does not exceed the threshold, and applying an optimization procedure to a treatment plan for radiation therapy of the patient using the modified dose value for the surrounding region.
[0010] The reference dose value and the defined dose value are reference targets, representing the purpose to be achieved by the radiotherapy. The dose value is usually provided in the SI unit of Gray (Gy). The dose value can be the average dose value of the entire considered area. The dose value can be dose-based (e.g., indicating the absorbed dose to be delivered to the target area or the surrounding area), or can be volume-based (e.g., indicating the absorbed dose to be delivered to a specified volume in the target area or the surrounding area). The dose value can be entered by a user, or it can be received by a computer implementing the method.
[0011] The surrounding region (or adjacent region, or OAR) need not be in physical contact with the targeted region, but may include areas of the patient other than the targeted region where the user wishes to limit or otherwise control absorbed dose.
[0012] The threshold value may be a fixed value, or may be a variable value that varies, for example, as a function of other parameters. In one example, the threshold value may be a fraction (eg, 50%) of a reference dose value for a target area of a patient.
[0013] If the defined dose value of the surrounding area does not exceed the threshold, the method modifies the defined dose value of the surrounding area. For example, if a fixed threshold of 10 Gy is used and the defined dose is 5 Gy, the method may increase the defined dose. In one example, the method may increase the defined dose so that it corresponds to the threshold. If the defined dose value already exceeds the threshold, the method may perform an optimization without modifying the defined dose value.
[0014] The optimization process seeks to determine parameters that are expected to result in an achieved dose that is as close as practicable (ie, with respect to any treatment and / or time constraints) to the modified dose values for the surrounding area and the reference dose value for the targeted area.
[0015] In a broad sense, the method for radiotherapy planning solves a technical problem that arises in the field of radiotherapy planning, that is, how to improve the generation of treatment plans. The method can improve the accuracy of the generated treatment plan and the speed of generation. The method also automates the generation of treatment plans. It is understandable that a typical user may require unrealistic low dose values for surrounding areas when planning a radiotherapy process. For example, when the reference dose value of the targeted area (e.g., cancerous mass) is 60Gy (the typical dose value range for the treatment of solid epithelial tumors is 60Gy to 80Gy), the user may set the defined dose value of the overlapping OAR to as low as 5Gy to determine a radiotherapy plan with minimal adverse effects on the OAR. In this example, the 5Gy target is so low that the optimization process is very inefficient and generally results in a suboptimal treatment plan. The inventor has realized that the automatic modification of the unrealistic defined dose value routinely improves the optimization speed and the accuracy of the generated treatment plan.
[0016] Further, the automatic modification of unrealistic defined dose values improves the robustness of the optimization; the optimization problem (i.e., the parameters that the optimization process seeks to optimize relative to the objectives and / or constraints) always remains realistic and feasible. Some techniques that aim for unrealistic low doses from the beginning of the optimization severely limit the space of solutions. This means that, potentially, the sole focus of these techniques may be on these unrealistic goals. Aiming for less aggressive goals and gradually reducing the goals based on the feasibility of the solution allows the optimizer to remain in a "wise" state. In other words, the techniques disclosed in this article enable the optimization to take into account the entire solution space, all objectives and all constraints, without causing the optimization to be stuck in a less favorable situation or optimization space.
[0017] Without the techniques disclosed herein, other techniques provide suboptimal plans, which often involve a slow optimization process (because the optimizer needs to run longer to reach some acceptable plan). Inappropriate starting values often result in extremely large cost function values that the computer (programming language) cannot handle efficiently (e.g., resulting in a "not-a-number" error).
[0018] In automating the process, the user is not burdened with selecting a defined dose value for the surrounding region, which may vary significantly between patients with different anatomy. The user may not initially know if the defined dose value is realistic for the particular patient under consideration. The method changes the input to a more reasonable starting value.
[0019] Optionally, the optimization process includes determining a dose distribution indicating expected doses in the target region and the surrounding region. The determination can be based on a reference dose value for the target region and a modified dose value for the surrounding region (i.e., a defined dose value for the surrounding region modified in response to determining that the defined dose value for the surrounding region is below a threshold).
[0020] Optionally, in response to determining that the dose distribution matches the modified dose value of the surrounding area, the optimization process includes: adjusting the modified dose value toward the defined dose value. During the iterative optimization process, it may happen that the modified dose value is iteratively (further) modified during each pass. The matching of the dose distribution (or its aspects, such as the expected dose in the target area or the surrounding area) does not need to be accurate, but if the two quantities are approximately equal, for example, within a 1% tolerance or within an absolute absorbance tolerance, such as within 0.1Gy, the two quantities can be considered to match. Then, the optimization process repeatedly determines the dose distribution (indicating the expected dose in the target area and in the surrounding area) until a stop criterion for the dose in the surrounding area is reached. The stop criterion can be, for example, a convergence criterion, such as a convergence criterion in which the obtained dose in the surrounding area changes less than a defined value between successive iterations, and / or can be a time-based criterion, such as a time-based criterion in which an optimization process in which a defined number of repetitions has been performed.
[0021] In this way, the optimization process seeks to develop treatment plans that achieve the constraint / target defined dose values for the surrounding region in a "gentler" manner compared to an optimization process without iterative modification of dose values. Using a stepwise, automated approach, the solution space of the optimization process remains computationally evaluable throughout the optimization process.
[0022] Optionally, during the optimization process, the modified dose value may be adjusted toward the defined dose value by a fixed value. Alternatively, the modified dose value may be adjusted by a variable value. For example, the value may be a percentage of the difference between the defined dose value and the current modified dose value.
[0023] Alternatively, the reference dose value for the targeted area may be a minimum dose value for treatment of the targeted area. The defined dose value for the surrounding area may be a maximum dose value for the surrounding area during treatment of the targeted area. These values may be selected by a professional practitioner based on a specific tissue or organ being treated nearby.
[0024] Alternatively, the optimization process can seek to minimize a cost function. The cost function can represent the dose excess in the surrounding area and / or the targeted area. That is, the optimization process can consider a function that maps the value of the optimizable parameter to a number that represents the "cost" of radiotherapy for at least the targeted area and the surrounding area. The cost can be called a loss. Alternatively, the optimization process can alternatively seek to maximize an objective function (or reward function, profit function, etc.).
[0025] Alternatively, the cost function can be a maximum dose cost function, which is effectively a hard barrier that can be applied to the targeted area or the surrounding area. The maximum dose cost function involves a penalty that takes effect whenever the dose value in a simulated area (e.g., a pixel or voxel) exceeds a maximum dose threshold. The cost function takes the maximum dose as input.
[0026] Alternatively, the cost function can be a serial cost function, which is generally used with serial surrounding regions. Serial anatomical structures are structures that would be harmed by a high dose even if it were confined to a small volume. Examples are the spinal cord and the intestine. This cost function imposes a large penalty on hot spots even if they are small in volume. The cost function takes as input an equivalent uniform dose and a power law exponent.
[0027] Optionally, the optimization process may seek to minimize a cost function with respect to one or more optimizable parameters to arrive at a radiation therapy plan that can treat the patient with clinically acceptable accuracy and desired efficacy.
[0028] Optimizable parameters may include a dose excess value, which is the amount of dose violation that is considered acceptable. Optimizable parameters may include beam weights; in a radiation beam, the beam may be divided into a number of beamlets, where the contribution under a (hypothetical) unit flux may be determined. The weight of the beamlet is then a scaling factor by which the unit flux of the beamlet may be scaled to reach another flux value. Optimizable parameters may include beam (or beamlet) angles, which may be the angle of the beam relative to a reference point (e.g., a radiation head of a radiotherapy system toward a targeted area). Optimizable parameters may include dose-volume histogram information, which provides information related to the cumulative dose per volume fraction of a targeted area or surrounding area. "Fractions" may be derived using a "fractionalization" process, where a sequence of radiotherapy deliveries (e.g., 45 fractions) is provided over a predetermined period of time, where each therapy delivery includes a specified fraction of the total prescribed dose. Optimizable parameters may include the number of radiation beams. Optimizable parameters may include the dose of each radiation beam. Optimizable parameters may include segment or control point shapes. Optimizable parameters may include segment or control point weights. The optimization process may adapt any or all of these optimizable parameters.
[0029] Optionally, the method for radiotherapy treatment planning can take into account multiple surrounding areas. That is, the treatment plan parameters can include defined dose values for multiple surrounding areas. The method can then determine whether each defined dose value for the corresponding surrounding area exceeds a corresponding threshold value, and then modify each corresponding defined dose value accordingly. In this way, the optimization process can be repeatedly applied to multiple surrounding areas of the patient. Of course, the threshold value can be the same for each surrounding area, or it can be different for each surrounding area (for example, taking into account different acceptable levels of absorbed dose rates between different tissues).
[0030] Optionally, the method for radiotherapy planning can consider multiple target areas. That is, the treatment plan parameters can include reference dose values for multiple target areas. Then, the method can consider each reference dose value, determine whether the defined dose value of the surrounding area exceeds the corresponding threshold, and can modify the defined dose value accordingly. In this way, the optimization process can be repeatedly applied to multiple target areas of the patient. Of course, for each target area, the threshold of the surrounding area can be the same. Of course, the method can consider multiple surrounding areas and multiple target areas. Both the surrounding area and the target area can be assigned a priority value, which indicates the importance of the area. For example, the method can, compared with the area of lower priority, place more emphasis on reaching a defined dose value or a reference dose value for a higher priority area. In one example, the optimization process can be initially performed on a high priority area and then turned to a low priority area.
[0031] Optionally, the threshold value (for the defined dose value) may be variable, depending on the cost function used in the optimization. Different cost functions may be more or less susceptible to computational inefficiencies when faced with unrealistically low defined dose values; in selecting a tailored threshold value for each corresponding cost function, potential inefficiencies are avoided.
[0032] Optionally, the treatment planning parameters may include an image of the patient, the image including the targeted region and the surrounding region. Some methods may be configured to process or pre-process image data. For example, some methods may convert received image data into a specific format, size, or resolution suitable for radiation therapy plan optimization, and / or may process the image data to perform segmentation, define the targeted region and the surrounding region.
[0033] Optionally, the method for radiation therapy planning may include accepting user input to a graphical user interface, wherein the user input includes a dose value for the targeted region and a defined dose value for the surrounding region.
[0034] Optionally, the method for radiation therapy treatment planning may include: outputting parameter values corresponding to the treatment plan. The parameter values may include any or all of the following: number of beams, angles of beams, dose per beam, beamlet weights, segment or control point shapes, segment or control point weights, dose-volume histogram information, dose excess values. In this way, the method may output parameter values (and, of course, configuration settings) for a radiation therapy system, thereby enabling delivery of a radiation plan to a patient.
[0035] Embodiments of another aspect include a data processing apparatus including a memory storing computer-readable instructions and a processor. The processor (or controller circuit) is configured to execute the instructions to perform a computer-implemented method for radiation therapy planning.
[0036] Embodiments of another aspect include a computer program comprising instructions that, when executed by a computer, cause the computer to perform a computer-implemented method for radiation therapy planning.
[0037] Embodiments of another aspect include a non-transitory computer-readable storage medium including instructions that, when executed by a computer, cause the computer to perform a computer-implemented method for radiation therapy planning.
[0038] The systems and methods described herein may be implemented in digital electronic circuitry or in computer hardware, firmware, software, or a combination thereof. The systems and methods may also be implemented as a computer program or computer program product, i.e., a computer program tangibly embodied in a non-transitory information carrier (e.g., in a machine-readable storage device or in a propagated signal) for performing or controlling the operation of one or more hardware modules. The computer program may be in the form of a stand-alone program, a computer program portion, or a plurality of computer programs, and may be written in any form of programming language (including compiled or interpreted languages), and may be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a data processing environment.
[0039] The present disclosure is described in specific embodiments. Other embodiments are also within the scope of the appended claims. For example, the steps of the present disclosure can be performed in a different order and still achieve the desired results. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Reference is made, by way of example only, to the accompanying drawings in which:
[0041] Figure 1 is a flow chart of a method for radiation therapy treatment planning in general;
[0042] Figure 2A is an example optimization process;
[0043] Figure 2B is an example optimization process for application in intensity modulated radiation therapy;
[0044] Figure 3 is a flow chart of a method for radiation therapy planning according to a working example; and
[0045] Figure 4A is the expected dose map associated with the radiotherapy treatment plan determined according to the traditional process;
[0046] Figure 4B is an expected dose map associated with a radiation therapy plan determined according to an embodiment;
[0047] Figure 5 is a radiotherapy system adapted to implement a radiotherapy plan determined according to an embodiment; and
[0048] Figure 6 It is a radiotherapy device or apparatus suitable for implementing the radiotherapy plan determined according to the embodiment. DETAILED DESCRIPTION
[0049] Treatment planning typically involves performing an optimization process to optimize several parameters with the goal of providing a sufficiently high dose to the targeted region (or Planned Target Volume (PTV)) while reducing the dose to surrounding healthy tissue. A clinically appropriate plan can be obtained by balancing different treatment planning goals, for example by prioritizing treatment planning goals related to dose coverage in the targeted region and then processing treatment plans related to the remaining surrounding regions. However, the user may request unrealistically low defined dose values in the surrounding regions, which can negatively impact the optimization process and, in turn, the treatment planning process.
[0050] Figure 1 A method for radiation therapy treatment planning in general is shown, which solves unrealistic defined dose values. In step 102, a computer receives treatment plan parameters, which include a reference dose value for a target region of a patient and a defined dose value for a surrounding region. In step 104, the computer determines whether the defined dose value for the surrounding region exceeds a threshold. In step 106, the computer modifies the defined dose value for the surrounding region in response to determining that the defined dose value for the surrounding region does not exceed the threshold, and applies an optimization process to a treatment plan for radiation therapy of the patient using the modified dose value for the surrounding region.
[0051] Any optimization process that seeks to determine the optimal (as feasible as possible) parameter values for receiving treatment plan parameters including reference dose values for the target area and defined dose values for the surrounding area is suitable for incorporation into the method according to various embodiments. For example, the method can implement the optimization process described in European patent application publication EP 3681600A1.
[0052] The compliance with the objectives and constraints involved in the optimization process can be quantified using a cost function, where the cost function output is a measure of the difference between the dose achieved by the treatment plan (e.g., the dose in a given region) and a reference dose (e.g., the maximum acceptable dose in that region).
[0053] FIG2 shows a block diagram of an example optimization process. The optimization process is applicable to the optimization of a set of parameters (i.e., one or more parameters) for a radiotherapy system. The one or more parameters may be referred to as optimizable parameters, or may be referred to as decision variables. Examples of optimizable parameters include parameters related to the characteristics of the radiation to be delivered by the radiotherapy system, such as the angle of the radiation beam, the level of radiation intensity at each angle, etc. Optimization is typically performed with respect to one or more parameters to shorten the beam on time, improve dose uniformity, etc. An example of a radiotherapy system will be described below.
[0054] The optimization module 200 may include an optimizer 212. Given the anatomical model 204 and one or more parameters 206, the purpose of the optimizer 212 is to provide a set of optimized parameters 216 that minimize the cost function 204. The optimizer includes at least one optimization algorithm. Examples of optimization algorithms include a simplex algorithm, a gradient-based algorithm, or an interior point algorithm, etc. or a combination thereof. Other optimization algorithms are also possible. The optimization example is shown in FIG. Training Guide, Document ID: LTGMON0530 (Elekta AB).
[0055] The cost function value 214 is the value of the cost function 204 when evaluated using the set of optimization parameters 216. The cost function value 214 is calculated by the optimizer 212 during optimization. The cost function value 214 may be referred to as a penalty. Optionally, the cost function value 214 is output by the optimizer 212.
[0056] The model 202 is a representation of the physical problem. The model 202 may correspond to an anatomical structure or a region thereof. The model 202 may include a targeted region (or PTV) and surrounding regions of healthy tissue or other critical structures (referred to as organs at risk or OARs). These regions may be determined and / or defined during a process called segmentation performed on a two-dimensional or three-dimensional image or model of the anatomical structure. These regions may be in the form of shell structures, which are structures generated to tune the dose delivered to tissue surrounding the target region, and they may be used to control dose distribution conformality. The dose distribution may be determined by a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. More details on how the dose may be determined are provided in Training Guide, Document ID: LTGMON0530 (Elekta AB).
[0057] The one or more parameters 206 can be optimizable parameters (also called decision variables) for which the optimizer 212 attempts to find an optimal value. The one or more parameters 206 can be initialized to predetermined values. In one example, for Intensity-Modulated Radiation Therapy (IMRT), the parameters 206 are weights of beamlets, and the parameters 206 can be initialized to predetermined weights. The weights of beamlets can be mapped to actual beamlet intensities during radiation therapy, where the intensity can be changed, for example, by changing the aperture size or the pulse time. Alternatively, the parameters 206 can be initialized to values determined in a previous step. For example, when performing further optimization procedures (or passes), the parameters can be initialized to values determined in previous optimization procedures (or passes).
[0058] The cost function 204 is a mathematical expression relating the parameters 206 and the model 202. The cost function 204 may be referred to as an objective function. The cost function 204 relates the dose distribution in the model 202 to a single value, the cost function value 214. For example, the cost function value 214 defines a penalty for violating an objective and / or constraint. The penalty may be evaluated by the optimizer 212 during optimization. Optionally, in constrained optimization, only the objective contributes to the cost function (i.e., the constraints remain "fixed" and the optimization process does not allow for constraint violations, since violating the constraint 208 would simply result in the treatment plan being rejected).
[0059] Constraints 208 include one or more conditions that must be satisfied by the optimization parameters 216. Constraints may include hard constraints (conditions that the parameters 206 need to satisfy). Constraints limit the set of available solutions. Constraints are used to define what is physically or clinically acceptable, rather than mathematically possible. For example, for IMRT, a hard constraint may be that the weights of beamlets must be non-negative (since negative beamlet weights are impossible). Note that constraints 208 are an optional feature.
[0060] Reference target 210 includes what optimizer 212 is trying to achieve. For example, in IMRT, reference targets can relate to dose-based targets and / or volume-based targets. Dose-based targets can include dose values (in Gy), such as the maximum, minimum, or average dose to a given area. For example, a dose-based target can be set in units of 10 mm. 3 The dose absorbed by the volume should not exceed 25 Gy. Volume-based targets can include relative volumes (fractions or percentages of volume) or absolute volumes (or in the case of two dimensions, absolute areas). For example, a volume-based target might state that the dose absorbed by 50% of the OAR volume should not exceed 5 Gy. Volumes (or areas) can be defined in terms of physical dimensions (e.g., in mm 2 、cm 2 、mm 3 、cm 3 In units). Additionally, the reference target 210 may include an indication of the cost function 204 to be used. Further, the reference target 210 may include an indication of the anatomical structure applicable to the objective to be achieved. The optimizer 212 will then determine the optimization parameters 216 that will result in an achieved objective value 218 close to the reference target 210. The reference target may be referred to as a treatment plan objective. Note that the reference target 210 is an optional feature.
[0061] Thus, reference target 210 may be anatomy-specific functions that establish dose and / or bioresponse targets. Constraints 208 are anatomy-specific functions that must be satisfied in order to achieve optimized fusion. When constraints are used with targets, the constraints are always satisfied, while the targets may not necessarily be satisfied (rather, they are goals that optimizer 212 attempts to achieve). In the case of multiple targets, priorities or preferences may be assigned to the targets, for example, a primary target is considered in a first optimization run, a secondary target is considered in a second optimization run following the first optimization run, a tertiary target is considered in a third optimization run following the second optimization run, and so on.
[0062] Cost function 204 together with model 202, parameters 206, constraints 208 (optional) and reference target 210 (optional) may be considered to represent an optimization problem to be solved. Cost function 204, constraints 208, reference target 210, alone or in combination, may be referred to as a treatment plan target.
[0063] The optimizer 212 aims to find a set of optimization parameters 206 that minimizes the cost function 204. The optimization parameters 216 are the output of the optimizer 212.
[0064] Optionally, optimizer 212 outputs cost function value 214. Cost function value 214 is the value of cost function 204 when evaluated using optimization parameters 216.
[0065] Optionally, the optimizer 212 outputs a target value 218. The target value 218 is comparable to a reference target. The target value 218 represents a value having the same unit as a given reference target. The target value 218 may be different from the cost function value 214. Unlike the cost function value 214, which may be a numerical value of an evaluation of a cost function, the target value 218 may have a physical meaning. In one example, when the reference target includes a target for dose measurement, the target value is also related to the dose (e.g., it has the unit Gy and / or the same physical meaning as the reference target). In one example, when the reference target includes a reference volume and a dose value, the target value is also related to the reference volume and the dose value (i.e., it has the same physical meaning as the reference target). The cost function value 214 may be a numerical value corresponding to a cost function evaluated using a set of optimization parameters. The target value 218 will be the percentage of the volume that receives the predetermined dose. In other words, the target value 218 is comparable to the reference target.
[0066] Figure 2B An example of a two-stage optimization process 250 for IMRT is shown. Although this example is applied to IMRT, it should be noted that the optimization process can be applied to other radiation therapy modes. For example, the optimization process can also be applied to Volumetric Modulated Arc Therapy (VMAT).
[0067] In IMRT, one or more radiation beams are directed to the tumor (targeted area). The intensity of each beam profile is not uniform. The goal of the optimization procedure 250 is to modify the intensity distribution so that a sufficiently high dose is delivered to the tumor while reducing the dose delivered to healthy organs (surrounding areas).
[0068] The optimization method of IMRT 250 includes two stages. The first stage 252 is Fluence Map Optimization (FMO), and the second stage 254 is to determine the configuration of the radiotherapy system. In FMO (stage 252), the optimal flux map is determined. Then, in the second stage, the optimal flux map is used to determine the configuration of the radiotherapy system.
[0069] For FMO, each beam is divided into a number of beamlets. Then, the contribution of each beamlet to the voxel per unit flux is calculated. During optimization, the weight of each beamlet is adjusted to minimize the cost function. The total dose distribution can be obtained by multiplying the weight with the contribution of each beamlet per unit flux. The total dose distribution can be compared with any constraints and / or reference targets to determine whether the optimization solution is appropriate.
[0070] Optimization consists in minimizing the cost function f(x) by determining suitable values of the parameters x based on certain constraints g. For FMO, the parameters x correspond to the weights of the beamlets (the parameters x may also be referred to as decision variables). The output of FMO (stage 252) includes the parameters x.
[0071] The constraints g include limits. Examples of limits are the minimum dose at a voxel corresponding to a target, or the maximum dose at a voxel corresponding to an OAR.
[0072] In one example, the cost function f(x) is:
[0073] f(x)=T1+T2+…+T3, (Equation 1)
[0074] Among them, for example, T1 = ∑x n ·d n , where T1 = ∑x n ·d n Corresponding to the weight of the sub-bundle, d n It represents the dose delivered to a voxel per beam at unit intensity. n is a non-optimizable parameter (e.g., it may depend on machine configuration and / or organizational properties). n Corresponding to the above model 202. In one example, the dose d n It can be determined by a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation uses a pencil beam algorithm or a convolution-based algorithm (which is faster but has reduced accuracy). n More details are in Training Guide, Document ID: LTGMON0530 (Elekta AB) is provided. The output of Phase 1 may include dose distribution.
[0075] In this example, the cost function f(x) is the sum of the total doses (T1, T2, ..., T3), where each T1, T2, ..., T3 represents the dose on a different structure. Note that alternative formulations of the problem to be solved can be used (e.g., by defining different cost functions or constraints).
[0076] In one example, the requirement that the dose at the target be above a certain amount can be stated as a constraint. Alternatively, such a requirement can be stated as a reference target.
[0077] Step 252 provides a combination of optimized parameters (e.g., beamlet weights x) that will provide an optimal intensity map (or flux map). In order to be ready for delivery by a radiotherapy system, a further stage (stage 153) is required to convert each optimized beamlet weight into a machine configuration that will deliver the optimal flux.
[0078] In stage 254, the output from stage 252 is converted into a configuration of a radiotherapy system. The configuration can be used by a radiotherapy device (examples of which are described herein) to deliver radiotherapy. For example, the configuration of the radiotherapy system includes a set (i.e., one or more) of through-hole configurations. The shape of the through-hole configuration can be selected to meet the same goals as in the first stage. The through-hole configuration can be achieved by a beam shaping device.
[0079] The through-hole configuration may be referred to as a control point or segment. The control point and / or segment includes radiation information (eg, energy, dose) and geometric information (segment or control point shape), such as gantry angle and blade position.
[0080] The shape and weights of the vias (ie, segment or control point weights) may be determined by applying algebraic and trigonometric considerations to the placement of the vias to implement the optimized beamlet weights of stage 252 .
[0081] Alternatively, stage 254 includes performing a second stage optimization flow to determine an optimized via configuration that will implement the optimized flux pattern determined in stage 252. The second stage optimization flow may be referred to as via optimization or via refinement.
[0082] Via optimization can include the following:
[0083] - A set of receive beamlet weights (e.g., from stage 252)
[0084] - Perform optimization to determine the optimal via shape. For example, optimization can be performed using Figure 2B The optimization process shown in is performed.
[0085] Other optimization processes are possible.
[0086] When the beam shaping device includes a multi-leaf collimator (MLC), through-aperture optimization may include:
[0087] - Receive a set of beamlet weights from the FMO and / or flux profile (eg, from stage 252).
[0088] - Convert the received profile into beamlet widths (openings between blade pairs). This results in segmentation.
[0089] - Optimize the weights of the resulting segments.
[0090] - Optionally, optimize the resulting segmented shapes (using a process called segmented shape optimization).
[0091] Note that the optimization step in stage 254 may include calculation of a dose distribution. The dose distribution may be calculated using a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation in stage 254 uses an MC-based algorithm (which is more accurate but computationally expensive). Further details of through-hole optimization are provided in Training Guide, Document ID: LTGMON0530 (Elekta AB).
[0092] Notice, Figure 2B The process may involve a specific angle (radiation beam angle). In one approach, a previous stage may be to determine the angle at which the radiation is to be delivered. The Beam Angle Optimization (BAO) process may be performed in Figure 2B , then Figure 2B The process can be performed for each determined angle.
[0093] Although Figure 2B The example involves a two-stage optimization process for IMRT (FMO at stage 252 and determination of configuration at stage 254), but it should be noted that alternative optimization methods such as Direct Machine Parameter Optimization (DMPO) can be used. In DMPO, the decision variables x correspond to parameters of the machine delivering radiation (e.g., MLC blade positions).
[0094] Returning to the cost function 202 in the optimization process, examples of cost functions include: target EUD, target penalty, secondary overdose, secondary underdose, serial, parallel, maximum dose, overdose DVH, underdose DVH. The cost function is briefly defined as follows. Each cost function provides a different calculation method. When the cost function includes any one of target penalty, parallel, overdose DVH and underdose DVH, the reference target is a dose value and a relative volume component (e.g., a percentage) or an absolute volume (e.g., in cc).
[0095] When the cost function includes any of target EUD, secondary overdose, seriality, maximum dose, or conformality, the reference target is the dose value.
[0096] Typically, the optimization process seeks to minimize a composite cost function consisting of the sum of cost functions that may be objectives or constraints. The cost function relates the non-uniform dose distribution to a single value. This value can be used to define a penalty for violating the objective or constraint. The system can evaluate this penalty value during the optimization process.
[0097] Cost functions such as serial, parallel, quadratic overdose, overdose DVH, or maximum dose are intended to limit the dose at the anatomical structure (e.g., if the dose exceeds a threshold, a penalty value is applied). Cost functions such as quadratic underdose or underdose DVH are intended to increase the dose at the anatomical structure. Cost functions such as target EUD and target penalty are intended to increase the dose at the structure. Some of the above cost functions also take a unitless number as input. The unitless number (k) can be, for example, a power law exponent.
[0098] The Target EUD cost function defines the structure as a target volume and represents the probability that the targeted cells will survive a given dose. The cost function requires a specified dose as input (i.e., the reference target of the cost function is the dose value). The specified dose (in Gy) is the Equivalent Uniform Dose (EUD). EUD is a uniform dose that, if delivered at the anatomical structure, has the same clinical effect as provided by a non-uniform dose distribution.
[0099] The target penalty cost function takes a prescribed dose and a minimum volume as input (i.e., the reference targets of the cost function are dose and relative volume). The target penalty is a quadratic penalty that starts with a threshold dose. It produces a steeper dose gradient after the target threshold is met. The target penalty is used to define a requirement that at least some fraction of the anatomical volume should receive at least the target dose.
[0100] The Quadratic Overdose (QO) cost function is a cost function used to limit the dose in the structure to which it is applied. QO can be applied to a target or an OAR. The QO cost function can be used to limit hot spots in a target. The QO cost function takes the maximum dose and the root-mean square (RMS) dose exceedance as input (i.e., the reference target includes two dose values). The maximum dose defines the dose that will trigger a penalty if exceeded. The RMS dose exceedance defines the acceptable amount of violation.
[0101] The quadratic underdose cost function is a cost function applied to the target volume. The quadratic underdose function implements a quadratic penalty. The cost function takes as input the minimum dose in Gy and the underdose in Gy (i.e., the reference target includes two dose values). The minimum dose is the minimum dose allowed in the target volume, and it represents the dose below which a penalty is triggered. The underdose is similar to the RMS dose overrun in that it defines the amount of acceptable violation in the prescription.
[0102] The serial cost function is often used with serial OARs. Serial anatomical structures are those that would be harmed by a high dose even if it were confined to a small volume. Examples are the spinal cord and the intestine. This cost function imposes a large penalty on hotspots even if they are small in volume. The cost function takes as input the EUD in Gy and a power law exponent p (i.e., a reference target that includes both a dose value and a unitless number). An example mathematical expression for the serial EUD cost function is as follows:
[0103]
[0104] where the cost function represents the sum of the i voxels in the patient's volume V, and where V i is the volume of the ith voxel, D i is the dose delivered to the i-th voxel, Δ is a reference dose value which is the maximum radiation dose in the target region of the patient and / or the surrounding region of the patient, and ε is a constant.
[0105] Parallel cost functions are often used for parallel OARs. Parallel structures are those for which very high doses to small volumes can be tolerated if the rest of the organ is spared. Examples are lungs, parotids, kidneys, liver. The cost function takes as input a reference dose in Gy, the average organ damage (i.e. a fraction of the volume of the structure that is likely to be sacrificed), and a power law exponent k (i.e. the reference target includes dose values, relative volumes, and unitless numbers).
[0106] The Maximum Dose (MXD) cost function is effectively a hard barrier that can be applied to the targeted region (structure) or the surrounding region (OAR). The Maximum Dose cost function has a penalty that takes effect whenever a voxel exceeds the maximum dose threshold. The cost function takes as input the maximum dose in Gy (i.e., the reference target includes the dose value). An example mathematical expression for the MXD cost function is as follows:
[0107]
[0108] where the cost function represents the sum of the i voxels in the patient's volume V, and where V i is the volume of the ith voxel, D iis the dose delivered to the i-th voxel, Δ is a reference dose value which is the maximum radiation dose in the target region of the patient and / or the surrounding region of the patient, and α is a maximum dose threshold.
[0109] The overdose DVH cost function takes as input a target dose in Gy and a maximum volume (i.e., a reference target includes a dose value and a relative volume). This cost function is applied to OARs. The goal is to keep the volume that receives more than the target dose below the relative volume.
[0110] The underdose DVH cost function takes as input a target dose in Gy and a minimum volume (i.e., a reference target including a dose value and a relative volume). The cost function is applied to the target volume. The goal is to keep the target volume that receives less than the target dose greater than the minimum volume.
[0111] Further details of the cost function are given in Training Guide, Document ID: LTGMON0530 (Elekta AB).
[0112] Figure 3 A method for radiotherapy planning according to an example is shown, including iterative adjustment of defined dose values for surrounding areas. Consider the case of prostate cancer radiotherapy planning. A user may wish to have a radiotherapy plan that can deliver a reference dose of 60Gy to the prostate while only a defined dose value of 5Gy is delivered to the rectum. Then, in step 302, the user enters these values as treatment plan parameters.
[0113] Then, at step 306, the computer implementing the method compares the defined dose value to a preset threshold of 50% of the reference dose (i.e., 30 Gy in this case). The computer determines that the defined dose value does not exceed (i.e., is not greater than) the threshold, and thus modifies the defined dose value to obtain a starting point for the optimization process. In this case, the computer sets the modified defined dose value to 30 Gy; however, those skilled in the art will appreciate that the threshold and the initial modified dose value are not necessarily the same.
[0114] At step 306, the computer starts an optimization process to modify the optimizable parameters and achieve a dose distribution or dose map that provides a sufficiently high dose (ideally, a reference dose value) to the prostate while reducing the dose to surrounding healthy tissue of the rectum.
[0115] Throughout the optimization process (eg, at the end of an optimization pass, or after convergence criteria are met), at step 308, the computer monitors the achieved doses in the prostate and rectum.
[0116] At step 310, the computer determines whether the achieved dose values in the surrounding region (ie, the dose values associated with the optimizable parameters at their current values) match the modified dose value of 30 Gy.
[0117] If the achieved dose value in the surrounding region successfully reaches the modified dose value of 30 Gy when the optimization process reaches its stopping criteria, then the computer decreases the modified dose value at step 312 and continues the optimization process (using the previously obtained optimizable parameter value as the starting point for the subsequent optimization pass) with the new modified dose value at step 306. For example, the optimization process may then seek to achieve a dose value of 20 Gy in the surrounding region.
[0118] If the achieved dose values in the surrounding region have not successfully reached the modified dose value of 30 Gy when the optimization process reaches its stopping criteria, the computer constrains the achieved doses in the prostate and rectum at step 314. The computer may then proceed to output the optimized parameter values associated with the achieved doses and any associated radiotherapy system configuration settings suitable for achieving those optimized parameter values and / or dose maps.
[0119] Figure 4A It is a dose map of a patient, which is overlaid on a medical image of the patient acquired using a computed tomography, CT scan. The diagram shows the dose distribution in the form of a color painting, where different colors represent different doses. Generally, darker colors indicate higher doses and vice versa. If two locations have exactly the same color, the dose in these two locations is the same. The diagram includes isodose lines, where each of these connecting curves shows a certain dose level. Any position at the periphery of a particular curve has the same dose. For example, one isodose curve may represent the dose at 95% of the defined dose value, while another isodose curve may represent the dose at 80% of the defined dose value.
[0120] The dose map indicates the expected radiation dose according to the radiotherapy plan (determined using the optimization process) for treating tumors in the oropharynx while seeking to minimize the dose delivered to the posterior neck. The radiotherapy plan is determined using a traditional process. As shown in the figure, the target area (which surrounds the gross and microscopic tumors and potentially affected lymph nodes) is the area delimited by the line marked with "A". The surrounding area of concern is the area within the area delimited by the dotted line marked with "B", which includes the posterior neck. A peak dose value of 49.22Gy is delivered to the target area. In the surrounding area of concern, the expected undesired dose in the central part is about 35Gy.
[0121] Figure 4B1 is a dose map for the same patient, where the associated radiotherapy plan is determined using the method according to the embodiment instead. As shown, the expected dose in the target area (again demarcated by the line marked "A") is essentially unchanged; the average dose to this area is only 4Gy different compared to the radiotherapy plan determined using the traditional process. However, the expected dose delivered to the surrounding area (area "B") is significantly reduced.
[0122] Figure 5 is a block diagram of an embodiment of a radiation therapy system 500 suitable for performing a method for radiation therapy treatment planning according to an embodiment. The example radiation therapy system 500 includes a computing system 510 within which a set of instructions for causing the computing system 510 to perform any one or more of the methods (or steps thereof) discussed herein can be executed. The computing system 510 can implement a treatment planning system. The computing system 510 can also be referred to as a computer. In particular, the methods described herein can be implemented by a processor or controller circuit 511 of the treatment planning system 510.
[0123] Computing system 510 should be considered as including any number or combination of machines, such as (one or more) computing devices, which independently or jointly execute a group (or multiple groups) of instructions to perform any one or more methods discussed herein. That is, in a computing system, hardware and / or software can be provided in a single computing device, or distributed in multiple computing devices. In some embodiments, one or more elements of a computing system can be connected (e.g., networked) to other machines such as a local area network (LAN), an intranet, an extranet, or the Internet. One or more elements of a computing system can be operated with the ability of a server or client machine in a client-server network environment, or operated as a peer-to-peer (peer-to-peer) (or distributed) network environment. One or more elements of the computing system may be a personal computer (PC), a tablet computer, a set-top box (STB), a personal digital assistant (PDA), a cellular phone, a web appliance, a server, a network router, a switch or a bridge, or any machine capable of executing a set of instructions (sequential or otherwise) that specify actions to be taken by the machine.
[0124] The computing system 510 includes a controller circuit 511 and a memory 513 (e.g., a read-only memory (ROM), a flash memory, a dynamic random access memory (DRAM), such as a synchronous DRAM (SDRAM) or a Rambus DRAM (RDRAM), etc.). The memory 513 may include a static memory (e.g., a flash memory, a static random access memory (SRAM), etc.) and / or an auxiliary memory (e.g., a data storage device) that communicate with each other via a bus (not shown).
[0125] The controller circuit 511 represents one or more general-purpose processors, such as a microprocessor, a central processing unit, or an accelerated processing unit. More specifically, the controller circuit 511 may include a complex instruction set computing (CISC) microprocessor, a reduced instruction set computing (RISC) microprocessor, a very long instruction word (VLIW) microprocessor, a processor implementing other instruction sets, or a processor implementing a combination of instruction sets. The controller circuit 511 may also include one or more special processing devices, such as an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), a digital signal processor (DSP), or a network processor. One or more processors of the controller circuit may have a multi-core design. The controller circuit 511 is configured to execute processing logic for executing the operations and steps discussed herein.
[0126] The computing system 510 may also include a network interface circuit 515. The computing system 510 may be communicatively coupled to an input device 520 and / or an output device 530 via an input / output circuit 516. In some embodiments, the input device 520 and / or the output device 530 may be an element of the computing system 510. The input device 520 may include an alphanumeric input device (e.g., a keyboard or a touch screen), a cursor control device (e.g., a mouse or a touch screen), an audio device (e.g., a microphone), and / or a tactile input device. The output device 530 may include an audio device (e.g., a speaker), a video display unit (e.g., a liquid crystal display (LCD) or a cathode ray tube (CRT)), and / or a tactile output device. In some embodiments, the input device 520 and the output device 530 may be provided as a single device, or as separate individual devices.
[0127] In some embodiments, the computing system 510 may include an image processing circuit 514. The image processing circuit 514 may be configured to process image data 580 (e.g., image or imaging data), such as medical images acquired from one or more imaging data sources, the treatment device 550, and / or the image acquisition device 540. The image processing circuit 514 may be configured to process or pre-process the image data 580. For example, the image processing circuit 514 may convert the received image data to a specific format, size, or resolution, etc. In some embodiments, the image processing circuit 514 may be combined with the controller circuit 511.
[0128] In some embodiments, the radiotherapy system 500 may also include an image acquisition device 540 and / or a treatment device 550. The image acquisition device 540 and the treatment device 550 are provided as a single device. In some embodiments, the treatment device 550 is configured to perform imaging, for example, in addition to providing treatment and / or during treatment. The treatment device 550 comprises the main radiation delivery component of the radiotherapy system.
[0129] The image acquisition device 540 can be configured to perform positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), single positron emission computed tomography (SPECT), X-ray, etc.
[0130] Image acquisition device 540 may be configured to output image data 580, which may be accessed by computing system 510. Treatment device 550 may be configured to output treatment data 560, which may be accessed by computing system 510.
[0131] The computing system 510 may be configured to access or acquire treatment data 560, planning data 570, and / or image data 580. The treatment data 560 may be acquired from an internal data source (e.g., from the memory 513) or an external data source (e.g., the treatment device 550 or an external database). The planning data 570 may be acquired from the memory 513 and / or an external source (e.g., a planning database). The planning data 570 may include information acquired from one or more of the image acquisition device 540 and the treatment device 550.
[0132] The above methods can be implemented by a computer program. The computer program may include computer code (e.g., instructions) arranged to instruct a computer to perform the functions of one or more of the above methods. Figure 1 , Figure 2 and / or Figure 3 The steps of each method described can be performed by computer code. The steps of the above method can be performed in any suitable order. The computer program and / or code for performing these methods can be provided to a device (e.g., a computer) on one or more computer-readable media (or more generally, a computer program product). The computer-readable medium can be transient (transitory) or non-transitory (non-transitory). One or more computer-readable media can be, for example, electronic, magnetic, optical, electromagnetic, infrared or semiconductor systems, or propagation media for data transmission (e.g., for downloading code via the Internet). Optionally, one or more computer-readable media can take the form of one or more physical computer-readable media, such as semiconductor or solid-state memory, magnetic tape, removable computer disk, random access memory (Random Access Memory, RAM), read-only memory (Read-Only Memory, ROM), rigid disk and optical disk, such as CD-ROM, CD-R / W or DVD. The instructions may also reside, in whole or at least in part, within the memory 513 and / or within the controller circuit 511 during execution thereof by the computing system 510 , the memory 513 and the controller circuit 511 also constituting computer-readable storage media.
[0133] In one embodiment, the modules, components, and other features described herein may be implemented as discrete components or integrated into the functionality of hardware components such as ASICS, FPGAs, DSPs, or similar devices.
[0134] A "hardware component" is a tangible (e.g., non-transitory) physical component (e.g., a set of one or more processors) that is capable of performing certain operations and may be configured or arranged in some physical manner. A hardware component may include dedicated circuitry or logic that is permanently configured to perform certain operations. A hardware component may include a dedicated processor, such as an FPGA or ASIC. A hardware component may also include programmable logic or circuitry that is temporarily configured by software to perform certain operations.
[0135] In addition, modules and components can be implemented as firmware or functional circuits in hardware devices. In addition, modules and components can be implemented with any combination of hardware devices and software components, or only with software (e.g., code stored or otherwise embodied in a machine-readable medium or a transmission medium).
[0136] Figure 6 A radiotherapy device suitable for implementing a radiation treatment plan determined according to an embodiment is depicted. A cross section through the radiotherapy device 600 includes a radiation head 610 and a beam receiving device 602, both of which are attached to a gantry 604. The radiation head 610 includes a radiation source 612 that emits a radiation beam 606. The radiation head 610 also includes a beam shaping device 618 that controls the size and shape of the radiation field associated with the beam.
[0137] The beam receiving device 602 is configured to receive radiation emitted from the radiation head 610 for the purpose of absorbing and / or measuring the radiation beam. In the illustrated view, the radiation head 610 and the beam receiving device 602 are positioned diametrically opposite each other.
[0138] The gantry 604 is rotatable and supports the radiation head 610 and the beam receiving device 602 so that they can rotate about a rotation axis 608, which can coincide with the patient longitudinal axis. The gantry provides rotation of the radiation head 610 and the beam receiving device 602 in a plane perpendicular to the patient longitudinal axis (e.g., a sagittal plane). Three gantry directions X can be defined. G , Y G , Z G , where Y G Direction perpendicular to the frame rotation axis. G The direction extends from the point on the gantry corresponding to the radiation head toward the gantry rotation axis. Therefore, with respect to the patient reference frame, Z G The direction changes as the rack rotates.
[0139] The radiation therapy device 600 also includes a support surface 620 on which a subject (or patient) is supported during radiation therapy. The radiation head 610 is configured to rotate about the rotation axis 608 so that the radiation head 610 directs radiation toward the subject from various angles around the subject to establish a prescribed dose of radiation at the targeted area while spreading the radiation dose received by healthy tissue to a larger area of healthy tissue.
[0140] The radiotherapy apparatus 600 is configured to deliver a radiation beam toward a radiation isocenter that is substantially located on the rotation axis 608 at the center of the gantry 604 regardless of the angle at which the radiation head 610 is positioned.
[0141] The rotatable gantry 604 and radiation head 610 are sized to allow for the presence of a central aperture 622. The central aperture 622 provides an opening sufficient to allow a subject to be positioned therethrough without the possibility of the subject being accidentally contacted by the radiation head 610 or other mechanical components as the gantry rotates the radiation head 610 about the subject.
[0142] The radiation head 610 emits a radiation beam 606 along a beam axis 624 (or radiation axis or beam path), wherein the beam axis 624 is used to define the direction in which the radiation head emits radiation. The radiation beam 606 is incident on a beam receiving device 602, which may include at least one of a beam blocker and a radiation detector. The beam receiving device 602 is attached to the gantry 604 on radially opposite sides of the radiation head 610 to attenuate and / or detect the radiation beam after the beam passes through an object.
[0143] Radiation beam axis 624 may be defined, for example, as the center or point of maximum intensity of radiation beam 606 .
[0144] The beam shaper 618 defines the spread of the radiation beam 606. The beam shaper 618 is configured to adjust the shape and / or size of the radiation field generated by the radiation source. The beam shaper 618 does this by defining a variable shaped through hole (also referred to as a window or opening) to collimate the radiation beam 606 to a selected cross-sectional shape. In this example, the beam shaper 618 may be provided by a combination of an aperture and an MLC. The beam shaper 618 may also be referred to as a beam modifier.
[0145] The radiation therapy device 600 can be configured to deliver radiation therapy treatments in a coplanar mode and a non-coplanar mode (also called an oblique mode). In coplanar treatment, radiation is emitted in a plane that is perpendicular to the axis of rotation of the radiation head 610. In non-coplanar treatment, radiation is emitted at an angle that is not perpendicular to the axis of rotation. To deliver coplanar treatment and non-coplanar treatment, the radiation head 610 can be moved between at least two positions, one position in which radiation is emitted in a plane perpendicular to the axis of rotation (coplanar configuration) and one position in which radiation is emitted in a plane that is not perpendicular to the axis of rotation (non-coplanar configuration).
[0146] In a coplanar configuration, the radiation head is positioned to rotate about an axis of rotation and in a first plane. In a non-coplanar configuration, the radiation head is tilted relative to the first plane so that the radiation field generated by the radiation head is directed at an oblique angle relative to the first plane and the axis of rotation. In a non-coplanar configuration, the radiation head is positioned to rotate in a respective second plane that is parallel to the first plane and offset from the first plane. Since the radiation beam is emitted at an oblique angle relative to the second plane, the beam sweeps out a cone as the radiation head rotates.
[0147] When the radiotherapy device is in both the coplanar mode and the non-coplanar mode, the beam receiving device 602 remains in the same position relative to the rotatable gantry. Therefore, the beam receiving device 602 is configured to rotate about the rotation axis in the same plane in both the coplanar mode and the non-coplanar mode. This can be the same plane as the plane in which the radiation head rotates.
[0148] The beam shaping device 610 is configured to reduce the spread of the radiation field in a non-coplanar configuration compared to a coplanar configuration.
[0149] Radiation therapy device 600 includes controller 630 programmed to control radiation source 612, beam receiving device 806, and gantry 802. Controller 840 may perform functions or operations such as treatment planning, treatment delivery, image acquisition, image processing, motion tracking, motion management, and / or other tasks related to the radiation therapy process.
[0150] The controller 630 is programmed to control features of the device 600 according to a radiotherapy treatment plan for irradiating a targeted area (also referred to as a targeted tissue) of a patient. The treatment plan includes information about a specific dose to be applied to the targeted tissue, as well as other parameters such as beam angles, dose-volume histogram information, the number of radiation beams to be used during therapy, the dose of each beam, etc. The controller 630 is programmed to control various components of the device 600, such as the gantry 604, the radiation head 610, the beam receiving device 602, and the support surface 620, according to the treatment plan. Using a method according to an embodiment, a treatment plan can be determined.
[0151] The hardware components of the controller 630 may include one or more computers (e.g., general-purpose computers, workstations, servers, terminals, portable / mobile devices, etc.); processors (e.g., central processing units (CPUs), graphics processing units (GPUs), microprocessors, digital signal processors (DSPs), field programmable gate arrays (FPGAs), dedicated or specially designed processors, etc.); memory / storage devices, such as memory (e.g., read-only memory (ROM), random access memory (RAM), flash memory, hard disk drives, optical disks, solid-state drives (SSDs), etc.); input devices (e.g., keyboards, mice, touch screens, models, buttons, knobs, trackballs, levers, handles, joysticks, etc.); output devices (e.g., displays, printers, speakers, vibration devices, etc.); circuits; printed circuit boards (PCBs); or other suitable hardware. The software components of the controller 630 may include operating device software, application software, etc.
[0152] The radiation head 610 can be connected to a head actuator 614, which is configured to actuate the radiation head 610, for example, between a coplanar configuration and one or more non-coplanar configurations. This can involve translation and rotation of the radiation head 610 relative to the frame. In some embodiments, the head actuator can include a curved guide rail along which the radiation head 610 can be moved to adjust the position and angle of the radiation head 610. The controller 630 can control the configuration of the radiation head 630 via the head actuator 614.
[0153] The beam shaping device 618 includes a shaping actuator 616. The shaping actuator is configured to control the position of one or more elements in the beam shaping device 618 to shape the radiation beam 606. In some embodiments, the beam shaping device 618 includes an MLC, and the shaping actuator 616 includes a device for actuating the blades of the MLC. The beam shaping device 618 may also include an aperture, and the shaping actuator 616 may include a device for actuating a stop of the aperture. The controller 630 may control the beam shaping device 618 via the shaping actuator 616.
[0154] The treatment plan may include positioning information of the beam shaping device 618. The positioning information of the beam shaping device 618 may include information indicating the configuration of one or more elements of the beam shaping device 618, such as the configuration of blades of the MLC of the beam shaping device 618, the configuration of an aperture of the beam shaping device 618, and / or the configuration of an opening (e.g., a window or a through hole) of the MLC, etc.
[0155] As described herein, the objective of an optimizer (or an optimization process) is to find a set of optimization parameters that minimizes a cost function. However, it should be understood that, alternatively and equivalently, the objective of an optimizer (or an optimization process) can be considered to be to find a set of optimization parameters that maximizes a reward function.
[0156] Unless otherwise specifically stated, as will be apparent from the following discussion, it should be understood that throughout the specification, discussions utilizing terms such as "receiving," "determining," "comparing," "enabling," "maintaining," "identifying," "obtaining," "accessing," etc., refer to the actions and processes of a computer system or similar electronic computing device that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system's memories or registers or other such information storage, transmission, or display devices.
[0157] Although certain embodiments have been described, these embodiments are presented only by way of example and are not intended to limit the scope of the present disclosure. In fact, the novel methods and devices described herein can be embodied in various other forms; in addition, various omissions, substitutions, and changes can be made in the form of the methods and devices described herein.
[0158] The following statements may be helpful in understanding the present disclosure:
[0159] Statement 1: A computer-implemented method for radiation therapy treatment planning, the method comprising: receiving treatment plan parameters, the treatment plan parameters comprising a reference dose value for a targeted area of a patient and a defined dose value for a surrounding area; determining whether the defined dose value for the surrounding area exceeds a threshold; and in response to determining that the defined dose value for the surrounding area does not exceed the threshold, modifying the defined dose value for the surrounding area, and applying an optimization process to a treatment plan for radiation therapy for the patient using the modified dose value for the surrounding area.
[0160] Statement 2: The method according to Statement 1, wherein the optimization process includes: determining a dose distribution indicating the expected dose in the target area and in the surrounding area based on the reference dose value of the target area and the modified dose value of the surrounding area.
[0161] Statement 3: A method according to Statement 2, wherein the optimization process includes: in response to determining that the dose distribution indicates that the expected dose in the surrounding region matches the modified dose value of the surrounding region, adjusting the modified dose value toward the defined dose value; and repeatedly determining the dose distribution until a stopping criterion for the dose in the surrounding region is reached.
[0162] Statement 4: A method according to any of the preceding statements, wherein: the reference dose value of the target area is a minimum dose value for treatment of the target area; and the defined dose value of the surrounding area is a maximum dose value of the surrounding area during treatment of the target area.
[0163] Statement 5: A method as described in any preceding statement, wherein said optimization procedure seeks to minimize a cost function representing dose excesses in said surrounding region and / or said targeted region.
[0164] Statement 6: The method of Statement 5, wherein the cost function is a maximum dose, an MXD, a cost function, or a serial cost function.
[0165] Statement 7: The method of Statement 5 or Statement 6, wherein the optimization process further seeks to minimize the cost function with respect to one or more optimizable parameters.
[0166] Statement 8: The method of Statement 5, Statement 6, or Statement 7, wherein the one or more optimizable parameters include one or more of the following: dose excess value, beamlet weight, beam angle, dose-volume histogram information, number of radiation beams, and dose per beam.
[0167] Statement 9: A method according to any of the preceding statements, wherein the treatment plan parameters include defined dose values for multiple surrounding areas, and the method includes: for each defined dose value of the surrounding area, determining whether the defined dose value of the surrounding area exceeds a threshold; and for each defined dose value of the surrounding area, in response to determining that the defined dose value of the surrounding area does not exceed the threshold, modifying the defined dose value of the surrounding area, and using the modified dose value of the surrounding area to apply an optimization process to the treatment plan for radiation treatment of the patient.
[0168] Statement 10: A method according to any of the preceding statements, wherein the treatment plan parameters include reference dose values for multiple target areas, and the method includes: for each reference dose value of the target area, determining whether the defined dose value of the surrounding area exceeds a threshold; and for each dose value of the target area, in response to determining that the defined dose value of the surrounding area does not exceed the threshold, modifying the defined dose value of the surrounding area, and using the modified dose value of the surrounding area to apply an optimization process to the treatment plan for the radiation therapy plan for the patient.
[0169] Statement 11: A method as recited in any preceding statement, wherein said threshold is a function of a dose value for said targeted region.
[0170] Statement 12: A method as recited in any preceding statement, wherein said threshold is selected from a plurality of thresholds, each threshold of said plurality of thresholds being associated with a respective cost function for said optimization procedure.
[0171] Statement 13: The method of any preceding statement, wherein said treatment planning parameters include at least one medical image of a patient, said at least one medical image including said target region and said surrounding region.
[0172] Statement 14: The method of any preceding statement, further comprising: accepting user input to a graphical user interface, said user input comprising said dose value for said targeted area and said defined dose value for said surrounding area.
[0173] Statement 15: The method according to any of the preceding statements further includes: outputting parameter values corresponding to the treatment plan, wherein the parameter values include one or more of the following: dose excess value, sub-beam weight, beam angle, dose-volume histogram information, number of radiation beams and dose per beam.
[0174] Statement 16: A data processing apparatus comprising: a memory storing computer executable instructions; and a processor configured to execute the instructions to perform the method according to any one of Statements 1 to 15.
[0175] Statement 17: A computer program comprising instructions which, when executed by a computer, cause the computer to carry out a method according to any one of Statements 1 to 15.
[0176] Statement 18: A non-transitory computer-readable storage medium comprising instructions which, when executed by a computer, cause the computer to perform the method of any one of Statements 1-15.
Claims
1. A computer-implemented method for radiation therapy planning, the method comprising: receiving one or more treatment planning parameters, the one or more treatment planning parameters comprising a reference dose value for a targeted region of a patient and a defined dose value for a surrounding region; determining whether the defined dose value of the surrounding area exceeds a threshold; as well as In response to determining that the defined dose value of the surrounding region does not exceed the threshold, the defined dose value of the surrounding region is modified, and an optimization procedure is applied to a treatment plan for radiation treatment of the patient using the modified dose value of the surrounding region.
2. The method according to claim 1, wherein: The optimization procedure includes determining a dose distribution indicating expected doses in the target region and in the surrounding region based on the reference dose value of the target region and the modified dose value of the surrounding region.
3. The method according to claim 2, wherein: The optimization process includes: In response to determining that the dose distribution indicates that the expected dose in the surrounding region matches the modified dose value for the surrounding region, adjusting the modified dose value towards the defined dose value; and The dose distribution is determined repeatedly until a stop criterion for the dose in the surrounding area is reached.
4. The method according to claim 1, wherein: The reference dose value of the target area is a minimum dose value for treatment of the target area; and The defined dose value of the surrounding area is a maximum dose value of the surrounding area during treatment of the target area.
5. The method according to claim 1, wherein: The optimization procedure reduces a cost function representing dose excesses in the surrounding region and / or the targeted region.
6. The method according to claim 5, wherein: The cost function is a maximum dose (MXD), a cost function or a serial cost function.
7. The method according to claim 5, wherein: The cost function is a serial cost function.
8. The method according to claim 5, wherein: The optimization process further reduces the cost function with respect to one or more optimizable parameters.
9. The method according to claim 8, wherein: The one or more treatment planning parameters include one or more of the following: number of beams, one or more beam angles, dose per beam, beamlet weights, one or more segment or control point shapes, one or more segment or control point weights, dose-volume histogram information, or dose excess values.
10. The method according to claim 1, wherein: The one or more treatment plan parameters include one or more defined dose values for a plurality of surrounding regions, and the method comprises: For each defined dose value of the surrounding area, determining whether the defined dose value of the surrounding area exceeds a threshold; and For each defined dose value of a surrounding area, in response to determining that the defined dose value of the surrounding area does not exceed a threshold, the defined dose value of the surrounding area is modified, and the optimized process is applied to the treatment plan for radiation treatment of the patient using the modified dose value of the surrounding area.
11. The method according to claim 1, wherein: The treatment plan parameters include one or more reference dose values for a plurality of target areas, and the method includes: For each reference dose value of the target area, determining whether the defined dose value of the surrounding area exceeds a threshold; and For each dose value of the targeted region, in response to determining that the defined dose value of the surrounding region does not exceed a threshold, the defined dose value of the surrounding region is modified, and an optimization procedure is applied to the treatment plan for the radiation therapy plan for the patient using the modified dose value of the surrounding region.
12. The method according to claim 1, wherein: The threshold is a function of the dose value of the targeted area.
13. The method according to claim 1, wherein: The threshold is selected from a plurality of thresholds, each threshold being associated with a respective cost function for the optimization procedure.
14. The method according to claim 1, wherein: The one or more treatment planning parameters include at least one medical image of a patient, the at least one medical image including the target region and the surrounding region.
15. The method of claim 1, further comprising: User input is accepted to a graphical user interface, the user input comprising the dose value for the targeted area and the defined dose value for the surrounding area.
16. The method of claim 1, further comprising: Output one or more parameter values corresponding to the treatment plan, wherein the parameter values include one or more of the following: the number of beams, one or more beam angles, the dose of each beam, one or more shot weights, one or more segment or control point shapes, one or more segment or control point weights, dose-volume histogram information, or a dose excess value.
17. A data processing device, comprising: a memory storing computer executable instructions; as well as A processor configured to execute the instructions to: receiving one or more treatment planning parameters, the one or more treatment planning parameters comprising a reference dose value for a targeted region of a patient and a defined dose value for a surrounding region; determining whether the defined dose value of the surrounding area exceeds a threshold; as well as In response to determining that the defined dose value of the surrounding region does not exceed the threshold, the defined dose value of the surrounding region is modified, and an optimization procedure is applied to a treatment plan for radiation treatment of the patient using the modified dose value of the surrounding region.
18. A computer program comprising instructions which, when executed by a computer, cause the computer to: receiving one or more treatment planning parameters, the one or more treatment planning parameters comprising a reference dose value for a targeted region of a patient and a defined dose value for a surrounding region; determining whether the defined dose value of the surrounding area exceeds a threshold; and In response to determining that the defined dose value of the surrounding region does not exceed the threshold, the defined dose value of the surrounding region is modified, and an optimization procedure is applied to a treatment plan for radiation treatment of the patient using the modified dose value of the surrounding region.
19. A non-transitory computer-readable storage medium comprising instructions which, when executed by a computer, cause the computer to: receiving one or more treatment planning parameters, the one or more treatment planning parameters comprising a reference dose value for a targeted region of a patient and a defined dose value for a surrounding region; determining whether the defined dose value of the surrounding area exceeds a threshold; and In response to determining that the defined dose value of the surrounding region does not exceed the threshold, the defined dose value of the surrounding region is modified, and an optimization procedure is applied to a treatment plan for radiation treatment of the patient using the modified dose value of the surrounding region.
Citation Information
Cited By
Dose distribution generation method and device and electronic equipment
CN121371528A
